Clinical Trials

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received approval from India’s drug regulator DCGI in late April. Glenmark is the first company in...

CTI BioPharma Corp. initiated PRE-VENT, a Phase III study evaluating pacritinib in hospitalized patients with severe COVID-19. PRE-VENT, a randomized, double-blind, placebo-controlled study, will compare pacritinib plus standard of care (SOC) versus placebo plus standard of care in 358...

The COVID-19 pandemic has exposed some significant frailties in the physical clinical supply chain. As governments, medical professionals and life science organisations around the world direct their energy and resources to curtailing the pandemic, a challenge that requires attention,...

Researchers at Queen’s University Belfast are leading a UK-wide clinical trial, offering an innovative cell therapy treatment for COVID-19 patients with acute respiratory failure. This clinical trial, led by Professor Danny McAuley and Professor Cecilia O’Kane, both researchers from the...

Pfizer and BioNTech announced that they intend to advance multiple SARS-CoV-2 vaccine candidates into human clinical testing, with the first clinical trials potentially beginning by late April. The two companies began their collaboration focused on developing a vaccine for...

Who would have thought a pandemic in this modern era would cripple the world, the strongest economies would be shaken, and end up being so vulnerable despite having the most modern technologies and processes at our disposal. That being...

The EndPandemic National Data Consortium announced that it has received commitments from six leading life sciences and information technology companies to join the Consortium, the formation of which was announced on March 30, 2020. The companies will work together...